Pancreatic Cancer Research

ResearcherFuda Cancer HospitalActive in the last 2 years

Lizhi Niu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-4221-1143; OpenAlex author ID A5101583287. Sources: ClinicalTrials.gov.

Their work

Papers
1 (first author 0, last author 1)
Trials
6
Grants
0
Labs led
0
Collaborators
2
Papers, trials and grants by year

2015: 2 trials · 2016: 2 trials · 2017: 1 trial · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 1

  1. Hypertension and tachycardia induced by irreversible electroporation in pancreatic cancer: An analysis based on clinical data. Last author DOI 10.4240/wjgs.v17.i9.110577↗

Trials 6

  1. PENS or TENS for Pain in Pancreatic Cancer Study chair NCT03331055↗
  2. Combination of Irreversible Electroporation and NK Immunotherapy for Advanced Pancreatic Cancer Study chair NCT02718859↗
  3. Simultaneous Gemcitabine and Irreversible Electroporation for Locally Advanced Pancreatic Cancer Study chair NCT02981719↗
  4. Anti-Tumor Immunity Induced by IRE of Unresectable Pancreatic Cancer Study chair NCT02343835↗
  5. Liver Cancer HepaSphere Combined With Cryosurgery Study chair NCT02545556↗
  6. Nano Drug Interventional Therapy Using Digital Subtraction Angiography（DSA） for Pancreatic Carcinoma Study chair NCT02449135↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Hongmei Li · 1 shared paper, 2025 · strength 0.30
  2. Yangyang Ma · 1 shared paper, 2025 · strength 0.30

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.